Latin America is the region with the highest burden of chronic kidney disease (CKD), in terms of disability-adjusted life years and premature deaths. This situation partly...
Safety Measures Clazakizumab was well tolerated, with the most common serious adverse events being serious infection (12.5% in the low-dose group, 9.4% in the medium-dose group,...